ARCHIVES

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

This article is from The Cancer Letter archive.

Vol. 28 No. 31 | August 2, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Director Says Gallo’s Work On HIV Should Have Been Recognized.

October 10, 2008

Sense Of Excitement, Challenges, Mark Healy’s Debut

April 26, 1991

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

DeVita Will Ask NTP To Return Some NCI Funs To help Cover Shortfall In Center Core Budget

January 18, 1980

DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites

April 24, 1981